Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

December 4, 2020

Study Completion Date

December 6, 2020

Conditions
Diabetes Mellitus, Type 2PreDiabetes
Interventions
BEHAVIORAL

Mediterranean Diet (Med-Plus)

Participants will follow the Med-Plus diet for 12 weeks, then switch to the alternate diet for another 12 weeks (no washout period).

BEHAVIORAL

Well-Formulated Ketogenic Diet (WFKD)

Participants will follow the WFKD diet for 12 weeks, then switch to the alternate diet for another 12 weeks (no washout period).

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03810378 - Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial | Biotech Hunter | Biotech Hunter